We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 5,171 results
  1. Death following rapidly progressive demyelinating disorder in a young female—a case report

    Multiple sclerosis (MS) is a debilitating, demyelinating disease of the central nervous system, with manifestations ranging from numbness and...

    C. U. Wickramasinghe, D. M. G. Fernando, ... H. R. S. D. Sumanasekara in Forensic Science, Medicine and Pathology
    Article 28 November 2022
  2. The association between cognition and gait disturbance in central nervous system demyelinating disorder with mild disability

    Introduction

    Gait disturbance in central nervous system (CNS) demyelinating disorders, including multiple sclerosis (MS) and neuromyelitis optica...

    Min Cheol Chang, Byung Joo Lee, ... Sunyoung Kim in BMC Neurology
    Article Open access 29 April 2023
  3. Demyelinating plaque-associated uveitis

    Purpose

    To report the clinical and fluorescein angiographic (FA) features of demyelinating plaque-associated uveitis (DPU), a subset of uveitis in...

    Alireza Hedayatfar, Pasha Anvari, ... Soon-Phaik Chee in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 19 October 2023
  4. Neuropathy in ARSACS is demyelinating but without typical nerve enlargement in nerve ultrasound

    Background

    To specify peripheral nerve affection in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) by correlating high-resolution...

    Katharina Kneer, Stephanie Straub, ... Alexander Grimm in Journal of Neurology
    Article Open access 23 January 2024
  5. Different visual evoked potentials in neuromyelitis optica spectrum disorder-related optic neuritis and idiopathic demyelinating optic neuritis: a prospective longitudinal analysis

    Background

    To investigate different visual evoked potential (VEP) patterns in neuromyelitis optica spectrum disorder-related optic neuritis (NMOSD-ON)...

    Cong Zheng, Ling Wang, ... Hui Yang in BMC Ophthalmology
    Article Open access 21 September 2022
  6. Risk of central nervous system demyelinating attack or optic neuritis recurrence after pediatric optic neuritis in Korea

    Purpose

    To investigate the rate of development of symptomatic central nervous system (CNS) demyelinating attacks or recurrent optic neuritis (ON)...

    Yeji Moon, Kyung-Ah Park, ... Jae Ho Jung in Neurological Sciences
    Article 19 October 2023
  7. Progressive demyelinating polyneuropathy after hematopoietic cell transplantation in metachromatic leukodystrophy: a case series

    Metachromatic leukodystrophy (MLD) is a neuro-metabolic disorder due to arylsulfatase A deficiency, causing demyelination of the central and...

    Shanice Beerepoot, Jaap Jan Boelens, ... Nicole I. Wolf in Journal of Neurology
    Article Open access 02 April 2024
  8. Corneal nerve fiber involvement in chronic inflammatory demyelinating polyneuropathy

    Background

    Despite the primary myelin-related pathophysiology, small fiber neuropathy (SFN) and axonal degeneration are also considered to be involved...

    Ezgi Keskiner-Ozturk, Semra Akkaya-Turhan, ... Pinar Kahraman-Koytak in Neurological Sciences
    Article 01 March 2023
  9. Anti-NMDA receptor encephalitis and overlap** demyelinating disorder in a 20-year old female with borderline personality disorder: proposal of a diagnostic and therapeutic algorithm for autoimmune encephalitis in psychiatric patients “case report”

    Background

    Anti-NMDA receptor encephalitis (NMDAR-E) is an autoimmune encephalitis (AE) mainly affecting young females. It typically presents with...

    David Weiss, Lisa Kertzscher, ... Michael Kluge in BMC Psychiatry
    Article Open access 15 July 2021
  10. Autonomic nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a literature review

    Background and aims

    Although dysautonomia is a well-recognized complication of acute demyelinating polyradiculoneuropathy, it is rarely reported and...

    Łukasz Rzepiński, Pietro Emiliano Doneddu, ... Eduardo Nobile-Orazio in Neurological Sciences
    Article 21 April 2023
  11. Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy

    Background

    To investigate Ranvier’s autoantibodies prevalence and isotypes in various peripheral neuropathy variants, compare clinical features...

    Lijie Zhang, Yuanyuan Zhang, ... Ying Fu in Journal of Neurology
    Article 21 May 2024
  12. Changes of retinal structure and visual function in patients with demyelinating transverse myelitis

    Purpose

    To identify the retina-structural and visual-functional alterations in the patients with aquaporin-4 (AQP4)-IgG-positive neuromyelitis optica...

    Jang Ho Lee, Yeji Moon, ... Jae Ho Jung in Neurological Sciences
    Article 08 August 2022
  13. Tumefactive demyelinating lesions: a challenging first manifestation of multiple sclerosis

    Matteo Azzimonti, Monica Margoni, ... Massimo Filippi in Journal of Neurology
    Article 28 December 2023
  14. Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder

    Background and aims

    Myelin oligodendrocyte glycoprotein (MOG) is an oligodendrocytopathy resulting in demyelination. We aimed to determine the...

    Manjunath Netravathi, Vikram Venkappayya Holla, ... Anita Mahadevan in Journal of Neurology
    Article 13 November 2020
  15. Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study

    Introduction

    Intravenous immunoglobulin (IVIG) is recommended as first-line therapy for chronic inflammatory demyelinating polyradiculoneuropathy...

    J. Bradley Layton, Mary E. Ritchey, ... Colin Anderson-Smits in Neurology and Therapy
    Article Open access 17 May 2023
  16. Subcutaneous immunoglobulins (SCIG) for chronic inflammatory demyelinating polyneuropathy (CIDP): A comprehensive systematic review of clinical studies and meta-analysis

    Background

    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) presents significant treatment challenges due to its chronic nature, varied...

    Ahmed Ramzi, Subhia Maya, ... Mostafa Ramzi Shiha in Neurological Sciences
    Article Open access 28 June 2024
  17. Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study

    Background and Aims

    The ProCID study evaluated the efficacy and safety of three doses of a 10% liquid intravenous immunoglobulin (IVIg) preparation...

    David R. Cornblath, Pieter A. van Doorn, ... D. Smolko in Drug Safety
    Article Open access 28 June 2023
  18. The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot–Marie–Tooth disease

    Background

    Charcot–Marie–Tooth disease (CMT) is a genetically and clinically heterogeneous group of inherited neuropathies. Monoallelic pathogenic...

    Feride Cinarli Yuksel, Paschalis Nicolaou, ... Kyproula Christodoulou in Journal of Neurology
    Article Open access 04 February 2023
  19. Sleep in multiple sclerosis and neuromyelitis optica spectrum disorder—the SEMN study

    Purpose

    This study aimed to (1) evaluate in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) the presence of...

    Nise Alessandra Carvalho Sousa, Carlos Mauricio Oliveira de Almeida, ... Ronaldo Marques Pontes Rabelo in Sleep and Breathing
    Article 18 April 2023
Did you find what you were looking for? Share feedback.